Literature DB >> 22359381

Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(-/-) null mice.

Nalini M Rajamannan1.   

Abstract

Calcific aortic valve disease (CAVD) is the most common indication for valve surgery in the USA. This study hypothesizes that CAVD develops secondary to Wnt3a/Lrp5 activation via oxidative-mechanical stress in eNOS null mice. eNOS(-/-) mice were tested with experimental diets including a control (n=20), cholesterol (n=20), cholesterol + Atorvastatin (n=20). After 23 weeks the mice were tested for the development of aortic stenosis by Echo, Histology, MicroCT, and RTPCR for bone markers. In vitro studies measured Wnt3a secretion from aortic valve endothelial cells and confirmed oxidative stress via eNOS activity. Anion exchange chromatography was performed to isolate the mitogenic protein. Myofibroblast cells were tested to induce bone formation. Cholesterol treated eNOS mice develop severe stenosis with an increase in Wnt3a, Lrp5, Runx2 (threefold increase (P<0.0001) in the bicuspid versus tricuspid aortic valves. Secretion of Wnt3a from aortic valve endothelium in the presence of abnormal oxidative stress was correlated with diminished eNOS enzymatic activity and tissue nitrite levels. Initial characterization of the architecture for a stem cell nice was determined by protein isolation using anion-exchange chromatography and cell proliferation via thymidine incorporation. Osteoblastogenesis in the myofibroblast cell occurred via Lrp5 receptor upregulation in the presence of osteogenic media. Targeting the Wnt3a/Lrp5 pathway in valve calcification and activation of osteogenesis is via an oxidative-mechanical stress in CAVD. These findings provide a foundation for treating this disease process by targeting the cross talk mechanism in a resident stem cell niche.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359381      PMCID: PMC3337361          DOI: 10.1002/jcb.24031

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  43 in total

1.  Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase.

Authors:  T C Lee; Y D Zhao; D W Courtman; D J Stewart
Journal:  Circulation       Date:  2000-05-23       Impact factor: 29.690

2.  Localization of caveolin 1 in aortic valve endothelial cells using antigen retrieval.

Authors:  Nalini M Rajamannan; Margaret J Springett; Larry G Pederson; Stephen W Carmichael
Journal:  J Histochem Cytochem       Date:  2002-05       Impact factor: 2.479

3.  The universal properties of stem cells as pinpointed by a simple discrete model.

Authors:  Zvia Agur; Yoaz Daniel; Yuval Ginosar
Journal:  J Math Biol       Date:  2002-01       Impact factor: 2.259

Review 4.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

5.  Experimental aortic valve stenosis in rabbits.

Authors:  Marie-Claude Drolet; Marie Arsenault; Jacques Couet
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

6.  Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat.

Authors:  V Shah; M Toruner; F Haddad; G Cadelina; A Papapetropoulos; K Choo; W C Sessa; R J Groszmann
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

7.  Bone formation and inflammation in cardiac valves.

Authors:  E R Mohler; F Gannon; C Reynolds; R Zimmerman; M G Keane; F S Kaplan
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

8.  Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.

Authors:  Nalini M Rajamannan; Malayannan Subramaniam; Margaret Springett; Thomas C Sebo; Marek Niekrasz; Joseph P McConnell; Ravinder J Singh; Neil J Stone; Robert O Bonow; Thomas C Spelsberg
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

9.  Experimental hypercholesterolemia induces apoptosis in the aortic valve.

Authors:  N M Rajamannan; G Sangiorgi; M Springett; K Arnold; T Mohacsi; L G Spagnoli; W D Edwards; A J Tajik; R S Schwartz
Journal:  J Heart Valve Dis       Date:  2001-05

10.  Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects.

Authors:  N M Rajamannan; N Caplice; F Anthikad; T J Sebo; T A Orszulak; W D Edwards; J Tajik; R S Schwartz
Journal:  J Heart Valve Dis       Date:  2001-11
View more
  16 in total

Review 1.  Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models.

Authors:  Robert M Weiss; Jordan D Miller; Donald D Heistad
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

2.  One Ion to Rule Them All: Combined Antibacterial, Osteoinductive and Anticancer Properties of Selenite-Incorporated Hydroxyapatite.

Authors:  Vuk Uskoković; Maheshwar Adiraj Iyer; Victoria M Wu
Journal:  J Mater Chem B       Date:  2017-01-23       Impact factor: 6.331

3.  Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase.

Authors:  Ramzi N El Accaoui; Sarah T Gould; Georges P Hajj; Yi Chu; Melissa K Davis; Diane C Kraft; Donald D Lund; Robert M Brooks; Hardik Doshi; Kathy A Zimmerman; William Kutschke; Kristi S Anseth; Donald D Heistad; Robert M Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-07       Impact factor: 4.733

Review 4.  Molecular and cellular aspects of calcific aortic valve disease.

Authors:  Dwight A Towler
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

5.  Identification of Immune-Associated Genes in Diagnosing Aortic Valve Calcification With Metabolic Syndrome by Integrated Bioinformatics Analysis and Machine Learning.

Authors:  Yufei Zhou; Wenxiang Shi; Di Zhao; Shengjue Xiao; Kai Wang; Jing Wang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

6.  Growth and maturation of heart valves leads to changes in endothelial cell distribution, impaired function, decreased metabolism and reduced cell proliferation.

Authors:  Lindsey J Anstine; Chris Bobba; Samir Ghadiali; Joy Lincoln
Journal:  J Mol Cell Cardiol       Date:  2016-10-15       Impact factor: 5.000

7.  TIEG1 is upregulated in Lrp5/6-mediated valve osteogenesis.

Authors:  Nalini M Rajamannan
Journal:  J Cell Biochem       Date:  2018-09-23       Impact factor: 4.429

Review 8.  Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease.

Authors:  Katherine Driscoll; Alexander D Cruz; Jonathan T Butcher
Journal:  Circ Res       Date:  2021-04-29       Impact factor: 17.367

9.  Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.

Authors:  Ling Sun; Nalini M Rajamannan; Philippe Sucosky
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

10.  Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient.

Authors:  Lia Millucci; Lorenzo Ghezzi; Eugenio Paccagnini; Giovanna Giorgetti; Cecilia Viti; Daniela Braconi; Marcella Laschi; Michela Geminiani; Patrizia Soldani; Pietro Lupetti; Maurizio Orlandini; Chiara Benvenuti; Federico Perfetto; Adriano Spreafico; Giulia Bernardini; Annalisa Santucci
Journal:  Mediators Inflamm       Date:  2014-04-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.